SYNACTHEN

This brand name is authorized in Australia, Estonia, Ireland, Lithuania, Malta, Netherlands, New Zealand, Turkey, United Kingdom

Active ingredients

The drug SYNACTHEN contains one active pharmaceutical ingredient (API):

1 Tetracosactide
UNII H86HJ92K8Y - COSYNTROPIN HEXAACETATE

Tetracosactide acetate consists of the first 24 amino acids occurring in the natural corticotropic hormone (ACTH) sequence and displays the same physiological properties as ACTH. In the adrenal cortex, it stimulates the biosynthesis of glucocorticoids, mineralocorticoids, and, to a lesser extent, androgens, which explains its therapeutic effect in conditions responsive to glucocorticoid treatment.

Read about Tetracosactide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SYNACTHEN Solution for injection or infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SYNACTHEN DEPOT Suspension for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H01AA02 Tetracosactide H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AA ACTH
Discover more medicines within H01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2832C
Country: EE Ravimiamet Identifier(s): 1109348, 1147946, 1489079, 1619265, 1664388, 1788497
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 302976, 302979
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1090519, 1090667, 1091320
Country: MT Medicines Authority Identifier(s): AA565/19302, AA565/19303, AA565/19304
Country: NL Z-Index G-Standaard Identifier(s): 12510440
Country: NL Z-Index G-Standaard, PRK Identifier(s): 2216
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 734, 735
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699874080366

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.